Fish oil treatment reduces several plaque parameters after 9 months

Media formats available:

GLP-1RA treatment effect in patients with T2DM and PAD
GLP-1RA treatment effect in patients with T2DM and PAD
AHA 2019
GLP-1RA treatment effect in patients with T2DM and PAD
- Prof. Subodh Verma, MD, PhD
A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial
A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial
AHA 2019
A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial
- Prof. Freek Verheugt, MD
Improved health status with SGLT2-inhibitor in HFrEF
Improved health status with SGLT2-inhibitor in HFrEF
AHA 2019
Improved health status with SGLT2-inhibitor in HFrEF
- Prof. Mikhail Kosiborod
Benefit on QoL with revascularization proportional to severity of angina symptoms
Benefit on QoL with revascularization proportional to severity of angina symptoms
AHA 2019
Benefit on QoL with revascularization proportional to severity of angina symptoms
- Prof. John Spertus

PACE-CME